Home Cart Sign in  
Chemical Structure| 835904-51-3 Chemical Structure| 835904-51-3

Structure of Synta66
CAS No.: 835904-51-3

Chemical Structure| 835904-51-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Synta66 is an effective inhibitor of the calcium ion channel Orai (the core of CRAC), suitable for studies related to calcium signaling in neuro-immune system diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Synta66

CAS No. :835904-51-3
Formula : C20H17FN2O3
M.W : 352.36
SMILES Code : FC1=CN=CC=C1C(NC2=CC=C(C=C2)C3=C(C=CC(OC)=C3)OC)=O
MDL No. :MFCD30719243

Safety of Synta66

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human platelets 10 µM 10 minutes To assess the role of Orai1 in platelet procoagulant activity, it was found that Synta66 reduced the percentage of procoagulant platelets but did not affect the supramaximal Ca2+ signal in platelets that had become procoagulant. Blood Adv. 2020 Jan 14;4(1):154-164
Human skeletal muscle cells 1 µM 15 min Inhibition of Orai1 Ca2+ channels, reducing ATP-stimulated IL-6 secretion Biology (Basel). 2023 Jul 7;12(7):968
MDA-MB-468 breast cancer cells 10 µM 15 min To assess the effects of Synta66 and YM58483 on ATP, EGF, and trypsin-induced Ca2+ influx. Results showed that Synta66 and YM58483 significantly inhibited CPA-induced Ca2+ influx and completely abolished the sustained Ca2+ influx induced by EGF and trypsin. Cell Mol Life Sci. 2018 Dec;75(24):4525-4537
Liver endothelial cells (LECs) 5 µM 2 minutes To investigate the Synta66-resistant component of VEGF-activated Ca2+ entry, it was found that Orai3 plays an important role in VEGF signaling. Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1987-94
Saphenous vein endothelial cells (SVECs) 5 µM 2 minutes To investigate the Synta66-resistant component of VEGF-activated Ca2+ entry, it was found that Orai3 plays an important role in VEGF signaling. Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1987-94
Cardiac microvascular endothelial cells (CMECs) 5 µM 2 minutes To investigate the Synta66-resistant component of VEGF-activated Ca2+ entry, it was found that Orai3 plays an important role in VEGF signaling. Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1987-94
Human umbilical vein endothelial cells (HUVECs) 5 µM 2 minutes To investigate the Synta66-resistant component of VEGF-activated Ca2+ entry, it was found that Synta66 had no effect on the rising phase but suppressed the later sustained phase. Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1987-94
Primary human skin-derived mast cells 10 µM 30 minutes Synta66 significantly inhibited SP-induced Ca2+ influx and degranulation. Front Immunol. 2022 Jan 20;12:803335
LAD2 cells 10 µM 30 minutes Synta66 robustly inhibited SP-induced Ca2+ influx, degranulation, and cytokine/chemokine generation (TNF-α, IL-8, and CCL-3). Front Immunol. 2022 Jan 20;12:803335
Human lung mast cells (HLMCs) 3 µM 30 minutes To investigate the inhibitory effect of Synta66 on FcεRI-dependent Ca2+ influx and mediator release in HLMCs. Results showed that 3 μM Synta66 reduced FcεRI-dependent Ca2+ influx by 54.8% and attenuated the release of histamine, leukotriene C4, and cytokines (IL-5/-8/-13 and TNFα). J Allergy Clin Immunol. 2012 Jun;129(6):1628-35. e2
Mouse peritoneal mast cells (PMCs) 10 µM 5 minutes Synta66 completely ablated SP-induced degranulation. Front Immunol. 2022 Jan 20;12:803335
Caco-2 cells 1 µM 5 minutes Attenuates SOCE and prevents any further effect of Lacticaseibacillus paracasei and Lactiplantibacillus plantarum postbiotics Mol Oncol. 2024 May;18(5):1123-1142
HT-29 cells 1 µM 5 minutes Attenuates SOCE and prevents any further effect of Lacticaseibacillus paracasei and Lactiplantibacillus plantarum postbiotics Mol Oncol. 2024 May;18(5):1123-1142

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Evans blue dye extravasation model and peritonitis model Intraperitoneal injection 10 mg/kg Single injection, lasting 3 hours Synta66 significantly attenuated SP-induced cutaneous vascular permeability and leukocyte (especially neutrophil) recruitment. Front Immunol. 2022 Jan 20;12:803335

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.84mL

0.57mL

0.28mL

14.19mL

2.84mL

1.42mL

28.38mL

5.68mL

2.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories